Phase 0 trials are the first-in-human studies for drugs that have been previously tested in animals. Usually a single drug dose is given to 10–15 people to gather preliminary data on how the drug is metabolised and what effect the drug has on the body. The dose of drug given is below what is thought to have a therapeutic effect.